info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142579 |
| CAS No | NA |
| Mol.F. | C18H30N2O5 |
| Mol.Wt. | 354.45 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142580 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.30 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142581 |
| CAS No | NA |
| Mol.F. | C17H28N2O5 |
| Mol.Wt. | 340.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142582 |
| CAS No | NA |
| Mol.F. | C13H20N2O3 |
| Mol.Wt. | 252.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142583 |
| CAS No | NA |
| Mol.F. | C15H22N2O6 |
| Mol.Wt. | 326.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142584 |
| CAS No | NA |
| Mol.F. | C16H24N2O6 |
| Mol.Wt. | 340.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142585 |
| CAS No | NA |
| Mol.F. | C16H26N2O5 |
| Mol.Wt. | 326.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142586 |
| CAS No | NA |
| Mol.F. | C13H20N2O2 |
| Mol.Wt. | 268.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142587 |
| CAS No | NA |
| Mol.F. | C19H28N2O3 |
| Mol.Wt. | 332.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142588 |
| CAS No | NA |
| Mol.F. | C14H20N2O5 |
| Mol.Wt. | 296.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142589 |
| CAS No | NA |
| Mol.F. | C12H18N2O4 |
| Mol.Wt. | 254.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142590 |
| CAS No | NA |
| Mol.F. | C15H24N2O5 |
| Mol.Wt. | 312.37g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142591 |
| CAS No | NA |
| Mol.F. | C18H31N2O8P |
| Mol.Wt. | 432.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142592 |
| CAS No | NA |
| Mol.F. | C13H18N2O5 |
| Mol.Wt. | 282.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142593 |
| CAS No | NA |
| Mol.F. | C16H26N2O7 |
| Mol.Wt. | 358.39 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142594 |
| CAS No | NA |
| Mol.F. | C13H22N2O4 |
| Mol.Wt. | 270.33 g/mol |
| INV STATUS | UNDER SYNTHESIS |
